HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice.

Abstract
The arginine residue at position 586 of the GluR-B subunit renders heteromeric alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)-sensitive glutamate receptor channels impermeable to calcium. The codon for this arginine is introduced at the precursor messenger RNA (pre-mRNA) stage by site-selective adenosine editing of a glutamine codon. Heterozygous mice engineered by gene targeting to harbor an editing-incompetent GluR-B allele synthesized unedited GluR-B subunits and, in principal neurons and interneurons, expressed AMPA receptors with increased calcium permeability. These mice developed seizures and died by 3 weeks of age, showing that GluR-B pre-mRNA editing is essential for brain function.
AuthorsR Brusa, F Zimmermann, D S Koh, D Feldmeyer, P Gass, P H Seeburg, R Sprengel
JournalScience (New York, N.Y.) (Science) Vol. 270 Issue 5242 Pg. 1677-80 (Dec 08 1995) ISSN: 0036-8075 [Print] United States
PMID7502080 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA Precursors
  • Receptors, AMPA
  • Glutamic Acid
  • Calcium
Topics
  • Alleles
  • Animals
  • Base Sequence
  • Calcium (metabolism)
  • Epilepsy (genetics, pathology)
  • Gene Targeting
  • Glutamic Acid (metabolism)
  • Heterozygote
  • Hippocampus (pathology)
  • In Situ Hybridization
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Molecular Sequence Data
  • Nerve Degeneration
  • Neurons (metabolism)
  • Polymerase Chain Reaction
  • Purkinje Cells (metabolism)
  • Pyramidal Cells (metabolism)
  • RNA Editing
  • RNA Precursors (genetics, metabolism)
  • Receptors, AMPA (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: